A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

528

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

DRUG

Zalcitabine

Trial Locations (24)

10019

Saint Luke's - Roosevelt Hosp Ctr, New York

10468

Bronx Veterans Affairs Med Ctr, The Bronx

11203

SUNY / Health Sciences Ctr at Brooklyn, Brooklyn

20060

Howard Univ, Washington D.C.

20422

Veterans Administration Med Ctr, Washington D.C.

30327

Intergrated Care Ctr, Atlanta

33125

Miami Veterans Administration Med Ctr, Miami

33136

Univ of Miami School of Medicine, Miami

53215

Dr Brian Buggy, Milwaukee

55101

St Paul Ramsey Med Ctr / HIV Program Office, Saint Paul

60612

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

63110

Washington Univ, St Louis

67214

Univ of Kansas School of Medicine, Wichita

75219

N Texas Ctr for AIDS & Clin Rsch, Dallas

80204

Denver Public Health Dept / Disease Control Services, Denver

87131

Univ of New Mexico School of Medicine, Albuquerque

90027

Kaiser Permanente Med Ctr, Los Angeles

90710

Kaiser Foundation Hosp, Harbor City

92101

Sharp Rees - Stealy Med Group, San Diego

94110

UCSF - San Francisco Gen Hosp, San Francisco

97201

Oregon Health Sciences Univ, Portland

432101228

Ohio State Univ Hosp Clinic, Columbus

775550882

Univ TX Galveston Med Branch, Galveston

02111

New England Med Ctr, Boston

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY